Cooper A J, Nieves E, Rosenspire K C, Filc-DeRicco S, Gelbard A S, Brusilow S W
Department of Neurology, Cornell University Medical College, New York, New York 10021.
J Biol Chem. 1988 Sep 5;263(25):12268-73.
Tracer quantities (in 0.2 ml) of 13N-labeled glutamate, alanine, or glutamine(amide) were administered rapidly (less than or equal to 2 s) via the portal vein of anesthetized adult male rats. Liver content of tracer at 5 s was 57 +/- 6 (n = 6), 24 +/- 1 (n = 3), and 69 +/- 7 (n = 3)% of the injected dose, respectively. Portal-hepatic vein differences for the corresponding amino acids were 17 +/- 6, 26 +/- 8, and 19 +/- 9% (n = 4), respectively, suggesting some export of glutamate and glutamine, but not of alanine, to the hepatic vein. Following L-[13N]glutamate administration, label rapidly appeared in liver alanine and aspartate (within seconds). The data emphasize the rapidity of nitrogen exchange via linked transaminases. By 30 s following administration of either L-[13N]glutamate or L-[13N]alanine, label in liver glutamate was comparable; yet, by 1 min greater than or equal to 9 times as much label was present in liver glutamine(amine) following L-[13N]glutamate administration than following L-[13N]alanine administration. Conversely, label in liver urea at 1 min was more pronounced in the latter case despite: (a) comparable total pool sizes of glutamate and alanine in liver; and (b) label incorporation from alanine into urea must occur via prior transfer of alanine nitrogen to glutamate. The data provide evidence for zonal differences in uptake of alanine and glutamate from the portal vein in vivo. The rate of turnover of L-[amide-13N]glutamine was considerably slower than that of L-[13N]alanine or of L-[13N]glutamate, presumably due in part to the higher concentration of glutamine in that organ. Nevertheless, it was possible to show that despite occasional suggestions to the contrary, glutamine(amide) is a source of urea nitrogen in vivo. The present findings continue to emphasize the rapidity of nitrogen exchange reactions in vivo.
将示踪量(0.2毫升)的13N标记的谷氨酸、丙氨酸或谷氨酰胺(酰胺)通过麻醉的成年雄性大鼠的门静脉快速(小于或等于2秒)注入。5秒时肝脏中示踪剂的含量分别为注射剂量的57±6(n = 6)、24±1(n = 3)和69±7(n = 3)%。相应氨基酸的门静脉-肝静脉差异分别为17±6、26±8和19±9%(n = 4),表明有一些谷氨酸和谷氨酰胺,但没有丙氨酸,被输出到肝静脉。给予L-[13N]谷氨酸后,标记物迅速出现在肝脏丙氨酸和天冬氨酸中(数秒内)。这些数据强调了通过联合转氨酶进行氮交换的快速性。给予L-[13N]谷氨酸或L-[13N]丙氨酸后30秒,肝脏谷氨酸中的标记物相当;然而到1分钟时,给予L-[13N]谷氨酸后肝脏谷氨酰胺(胺)中的标记物比给予L-[13N]丙氨酸后多9倍以上。相反,尽管:(a)肝脏中谷氨酸和丙氨酸的总库大小相当;且(b)丙氨酸氮必须先转移到谷氨酸才能掺入尿素,但在后者情况下1分钟时肝脏尿素中的标记物更明显。这些数据为体内门静脉中丙氨酸和谷氨酸摄取的区域差异提供了证据。L-[酰胺-13N]谷氨酰胺的周转速度比L-[13N]丙氨酸或L-[13N]谷氨酸慢得多,这可能部分是由于该器官中谷氨酰胺浓度较高。然而,有可能表明,尽管偶尔有相反的说法,但谷氨酰胺(酰胺)是体内尿素氮的一个来源。目前的研究结果继续强调了体内氮交换反应的快速性。